Since his appointment as Secretary of Health and Human Services, Robert F. Kennedy Jr. has brought sharp attention and considerable controversy to the department’s operations and priorities. In recent days, Kennedy has navigated immense national scrutiny following the release of troubling new CDC data on autism, which he highlighted at a major press conference in Washington. The data, which points to an alarming rise in autism diagnoses, is being positioned by Kennedy as evidence for his longstanding concerns about chronic disease and environmental health, thrusting these issues to the forefront of the national health agenda.
Kennedy’s stewardship of the department has been marked by sweeping structural changes aimed at realigning HHS with what he calls its “core mission.” Under his direction, the Make America Healthy Again campaign has taken center stage, focusing on reversing chronic disease trends and overhauling standards for processed food and chemical exposures. He has criticized the FDA’s regulatory approach, arguing for more aggressive scrutiny of food additives and environmental toxins. His vision is to curb epidemics of diabetes, obesity, and neurodevelopmental conditions through regulatory reform and public education.
However, these ambitions have collided with significant internal and external obstacles. In the past month, Kennedy oversaw deep organizational cuts, including the termination of approximately 10,000 positions across HHS, a move intended to streamline operations and eliminate what the administration described as inefficiencies. Yet, these cuts prompted backlash after it was revealed that critical programs—such as the CDC’s branch on lead poisoning prevention—were mistakenly included. In response, Kennedy announced that some of these programs and roles would be reinstated, citing the administration’s willingness to correct errors and acknowledging that essential research and prevention work had been unintentionally disrupted.
Kennedy’s approach has generated friction with both traditional public health experts and his own grassroots supporters. Some in the “Make America Healthy Again” movement have expressed disillusionment over his perceived slow pace in implementing campaign promises, such as blocking mRNA-based COVID-19 vaccines and eliminating fluoride from public water supplies. Meanwhile, the Trump administration, under which Kennedy serves, prioritizes other policy areas, creating tension over resource allocation and strategic focus.
The department’s capacity to respond to ongoing public health crises has also been tested. A severe measles outbreak, with over 600 cases reported in more than 20 states, has drawn national attention. The epicenter in West Texas has seen the tragic deaths of unvaccinated children, spurring Kennedy to travel personally to affected communities and reiterate his stance on vaccine safety and parental choice. At the same time, threats of a potential bird flu pandemic have further strained HHS resources as the secretary grapples with filling key vacancies and stabilizing the department’s leadership after high-profile resignations.
Kennedy’s own public statements continue to court controversy. He has promoted unconventional and scientifically unsubstantiated treatments, such as cod liver oil for measles, and advocated for policies like cellphone bans in schools based on disputed health risks. This embrace of alternative health perspectives has drawn sharp criticism from established medical authorities concerned about undermining proven public health measures.
Despite these challenges, Kennedy remains a highly visible figure, using his platform to advance a contentious vision for American health policy while pledging to remedy missteps and refocus the department’s efforts on chronic disease prevention and environmental health. The coming weeks will likely test his ability to balance political pressures, scientific consensus, and public demand for effective health leadership.